hydroxyindoleacetic acid has been researched along with Low Back Ache in 1 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Degenhardt, BF | 1 |
Darmani, NA | 1 |
Johnson, JC | 1 |
Towns, LC | 1 |
Rhodes, DC | 1 |
Trinh, C | 1 |
McClanahan, B | 1 |
DiMarzo, V | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Effects of Regular OMT on Stress Levels and Cognitive Function in OMS-I Students at Touro COM-NY Harlem[NCT06125574] | 10 participants (Actual) | Interventional | 2023-06-15 | Completed | |||
Hypoalgesic Effects of Specific vs Non-specific Cervical Manipulation in Healthy Subjects[NCT03541538] | 21 participants (Actual) | Interventional | 2018-06-20 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for hydroxyindoleacetic acid and Low Back Ache
Article | Year |
---|---|
Role of osteopathic manipulative treatment in altering pain biomarkers: a pilot study.
Topics: Adult; Amides; Arachidonic Acids; beta-Endorphin; Biomarkers; Endocannabinoids; Ethanolamines; Femal | 2007 |
Role of osteopathic manipulative treatment in altering pain biomarkers: a pilot study.
Topics: Adult; Amides; Arachidonic Acids; beta-Endorphin; Biomarkers; Endocannabinoids; Ethanolamines; Femal | 2007 |
Role of osteopathic manipulative treatment in altering pain biomarkers: a pilot study.
Topics: Adult; Amides; Arachidonic Acids; beta-Endorphin; Biomarkers; Endocannabinoids; Ethanolamines; Femal | 2007 |
Role of osteopathic manipulative treatment in altering pain biomarkers: a pilot study.
Topics: Adult; Amides; Arachidonic Acids; beta-Endorphin; Biomarkers; Endocannabinoids; Ethanolamines; Femal | 2007 |